Suppr超能文献

SARS-CoV-2 感染患者嗅觉和味觉功能障碍的危险因素。

Risk Factors for Olfactory and Gustatory Dysfunctions in Patients with SARS-CoV-2 Infection.

机构信息

Department of Otorhinolaryngology, San Gerardo Hospital, Monza, Italy.

Department of Otorhinolaryngology, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.

出版信息

Neuroepidemiology. 2021;55(2):154-161. doi: 10.1159/000514888. Epub 2021 Apr 1.

Abstract

INTRODUCTION

Smell and taste loss are characteristic symptoms of SARS-CoV-2 infection. The aim of this study is to investigate the prevalence and risk factors associated with olfactory and gustatory dysfunctions in coronavirus disease (COVID-19) patients.

METHODS

We conducted an observational, retrospective study on 376 patients with documented SARS-CoV-2 infection admitted to the San Gerardo Hospital in Monza, Italy, from March to July 2020. All patients answered a phone questionnaire providing information on age, sex, smoking status, and clinical characteristics. Adjusted odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were estimated through logistic regression models including relevant covariates.

RESULTS

The prevalence of olfactory and gustatory dysfunctions in COVID-19 patients was 33.5 and 35.6%, respectively. Olfactory dysfunctions were significantly directly associated with current smoking and history of allergy, the multivariable ORs being 6.53 (95% CI 1.16-36.86) for current smokers versus never smokers, and 1.89 (95% CI 1.05-3.39) for those with an allergy compared to those without any allergy. Respiratory allergy in particular was significantly associated with olfactory dysfunctions (multivariable OR 2.30, 95% CI 1.02-5.17). Significant inverse associations were observed for patients aged 60 years or more (multivariable OR 0.33, 95% CI 0.19-0.57) and hospitalization (multivariable OR 0.22, 95% CI 0.06-0.89). Considering gustatory dysfunctions, after allowance of other variables a significant direct association was found for respiratory allergies (OR 2.24, 95% CI 1.03-4.86), and an inverse association was found only for hospitalization (OR 0.21, 95% CI 0.06-0.76).

CONCLUSION

Our study indicates that current smoking and history of allergy (particularly respiratory) significantly increase the risk for smell loss in COVID-19 patients; the latter is also significantly associated to taste loss. Hospitalization has an inverse association with the risk of olfactory and gustatory dysfunctions, suggesting that these may be symptoms characteristics of less severe SARS-CoV-2 infection.

摘要

介绍

嗅觉和味觉丧失是 SARS-CoV-2 感染的特征性症状。本研究旨在调查冠状病毒病(COVID-19)患者嗅觉和味觉功能障碍的患病率和相关危险因素。

方法

我们对 2020 年 3 月至 7 月期间因 SARS-CoV-2 感染入住意大利蒙扎圣杰尔达医院的 376 名患者进行了一项观察性、回顾性研究。所有患者均通过电话问卷提供了年龄、性别、吸烟状况和临床特征信息。通过包括相关协变量的逻辑回归模型估计调整后的比值比(OR)和相应的 95%置信区间(CI)。

结果

COVID-19 患者嗅觉和味觉功能障碍的患病率分别为 33.5%和 35.6%。嗅觉功能障碍与当前吸烟和过敏史显著直接相关,当前吸烟者与从不吸烟者相比,多变量 OR 为 6.53(95%CI 1.16-36.86),过敏者与无过敏者相比,多变量 OR 为 1.89(95%CI 1.05-3.39)。特别是呼吸道过敏与嗅觉功能障碍显著相关(多变量 OR 2.30,95%CI 1.02-5.17)。年龄在 60 岁或以上(多变量 OR 0.33,95%CI 0.19-0.57)和住院(多变量 OR 0.22,95%CI 0.06-0.89)与嗅觉功能障碍呈显著负相关。考虑到味觉功能障碍,在允许其他变量后,呼吸道过敏与嗅觉功能障碍呈显著正相关(OR 2.24,95%CI 1.03-4.86),而仅与住院呈负相关(OR 0.21,95%CI 0.06-0.76)。

结论

我们的研究表明,当前吸烟和过敏史(特别是呼吸道过敏)显著增加了 COVID-19 患者嗅觉丧失的风险;后者也与味觉丧失显著相关。住院与嗅觉和味觉功能障碍的风险呈负相关,这表明这些可能是 SARS-CoV-2 感染程度较轻的症状特征。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验